High-dimensional characterization of post-acute sequalae of Covid-19
nature.com
nature.com
> To our knowledge, this is the largest post-acute COVID-19 study to date involving 73,435 non-hospitalized patients with COVID-19, and 4,990,835 controls (corresponding to 2,070,615.52 person years of follow-up), and 13,654 hospitalized patients with COVID-19, and 13,997 patients hospitalized with seasonal influenza (corresponding to 12,179.05 person years of follow-up). We leveraged the breadth and depth of the US Department of Veterans Affairs national health care databases — the largest nationally integrated healthcare delivery sys- tem in the US — to undertake a comprehensive high-dimensional com- parative approach (relative to control groups) to identify the 6-months health outcomes and clinical manifestations in COVID-19 patients who survived the first 30 days of COVID-19 illness.